SCHEMBL6329283

SCHEMBL6329283

CC(C)(C)OC(=O)N1CC2CN(c3ccc(-c4cc5ccccc5s4)nc3)CC2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.43
USP30 Q70CQ3 1/20 0.43
KDM1A O60341 1/20 0.41
ACKR3 P25106 1/20 0.41
MMP13 P45452 1/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
GPR119 Q8TDV5 4/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OGFRL1 Q5TC84 1/20 0.38
ATR Q13535 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
DCK P27707 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL928241 0.81 CHRNA7 (0.60) KDM1ACHRNB2CHRNA7CHRNA4CYP11B1
SCHEMBL6329284 0.81 KDM1A (0.38) USP30KDM1AACKR3MMP13GPR119
SCHEMBL6324400 0.79 CHRNB2 (0.53) PDE10AUSP30CHRNB2CHRNA7CHRNA4
SCHEMBL652572 0.77 PDE10A (0.54) PDE10AUSP30GPR119OPRM1OPRD1
SCHEMBL652571 0.77 PDE10A (0.54) PDE10AUSP30GPR119OPRM1OPRD1
SCHEMBL930345 0.77 CHRNB2 (0.60) KDM1ACHRNB2CHRNA7CHRNA4CYP11B1
Trifluoroacetic Acid SCHEMBL1789639 0.77 CHRNB2 (0.53) KDM1ACHRNB2CHRNA7CHRNA4CYP11B1
SCHEMBL31173949 0.77 GPR119 (0.46) PDE10AUSP30GPR119
SCHEMBL10256688 0.77 GPR119 (0.46) PDE10AUSP30GPR119
SCHEMBL6323845 0.76 CHRNB2 (0.47) PDE10AUSP30CHRNB2CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065178-A1 Substituted diazabicycloakane derivatives ABBOTT LABORATORIES 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065178-A1 Substituted diazabicycloakane derivatives CHRNA7, CHRNA1, CHRNA5 PDE10A 1088/4885USP30 4503/4885KDM1A 910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.